Precursor lesions of uterine serous carcinoma - review of the literature

被引:0
|
作者
Sobczuk, Anna [1 ]
Wrona, Marcin [1 ]
Pertynski, Tomasz [1 ]
机构
[1] Inst Cemtrum Zdrowia Matki Polki, Klin Ginekol & Chorob Menopauzy, Kierown Klin, PL-93338 Lodz, Poland
来源
PRZEGLAD MENOPAUZALNY | 2007年 / 6卷 / 06期
关键词
uterine serous carcinoma (USC); endometrial glandular dysplasia (EmGD); serous endometrial intraepithelial carcinoma (sEIC); minimal uterine serous carcinoma (MUSC); noninvasive uterine serous carcinoma (NUSC); uterine surface serous carcinoma (USSC);
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Uterine serous carcinoma (USC) is an uncommon but aggressive type of endometrial cancer associated with rapid progression of disease and a poor prognosis. The morphological and clinical features of the typical USC have been well delineated, but its precursor lesion is still under debate in terms of morphology as well as terminology. The putative precursor lesion of USC previously designated as endometrial intraepithelial carcinoma (EIC) or endometrial adenocarcinoma in situ or uterine surface carcinoma is now being referred to as serous EIC. Serous EIC is defined morphologically as replacement of endometrial surface epithelium and glands by frankly malignant cells that resemble the cells of the invasive high-grade endometrial carcinoma. Serous EIC is commonly associated with extrauterine serous carcinoma. Therefore it may be an early form of cancer rather than a precursor lesion. Endometrial glandular dysplasia (EmGD) is a newly defined entity that is commonly and specifically associated with serous EIC and USC. It has been proposed as a true precancerous lesion of USC based on recent studies showing morphological and molecular linkages between these 2 lesions.
引用
收藏
页码:376 / 380
页数:5
相关论文
共 50 条
  • [31] Precursor lesions for uterine leiomyosarcoma
    Mittal, Khush
    HUMAN PATHOLOGY, 2007, 38 (08) : 1289 - 1289
  • [32] Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma
    Salvador, Shannon
    Rempel, Allan
    Soslow, Robert A.
    Gilks, Blake
    Huntsman, David
    Miller, Dianne
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : 408 - 417
  • [33] A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome
    Faratian, D.
    Stillie, A.
    Busby-Earle, R. M. C.
    Cowie, V. J.
    Monaghan, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 972 - 978
  • [34] Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma
    Sagae, Satoru
    Susumu, Nobuyuki
    Viswanathan, Akila N.
    Aoki, Daisuke
    Backes, Floor J.
    Provencher, Diane M.
    Vaughan, Michelle
    Creutzberg, Carien L.
    Kurzeder, Christian
    Kristensen, Gunnar
    Lee, Chulmin
    Kurtz, Jean-Emmanuel
    Glasspool, Rosalind M.
    Small, William, Jr.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : S83 - S89
  • [35] Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
    Gross, Amy L.
    Kurman, Robert J.
    Vang, Russell
    Shih, Ie-Ming
    Visvanathan, Kala
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [36] SUB-CLINICAL STAGES OF CARCINOMA OF THE UTERINE CERVIX AND POSSIBLE PRECURSOR LESIONS
    CHRISTOPHERSON, WM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (07): : 1021 - 1026
  • [37] Morphologic variants of uterine serous carcinoma
    Duncanson, ER
    Baergen, RN
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (04) : 653 - 653
  • [38] Molecular Pathogenesis of Uterine Serous Carcinoma
    Satoru Nagase
    Fumihiko Suzuki
    Hideki Tokunaga
    Masafumi Toyoshima
    Hiroki Utsunomiya
    Hitoshi Niikura
    Nobuo Yaegashi
    Current Obstetrics and Gynecology Reports, 2014, 3 (1) : 33 - 39
  • [39] UTERINE PAPILLARY SEROUS CARCINOMA REVISITED
    HENDRICKSON, MR
    LONGACRE, TA
    KEMPSON, RL
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 261 - 263
  • [40] Treatment of uterine papillary serous carcinoma
    Ricci, Stephanie
    Fader, Amanda Nickles
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 819 - 827